
PMC:7200337 / 74866-75049
Annnotations
LitCovid-PD-FMA-UBERON
{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T663","span":{"begin":5,"end":14},"obj":"Body_part"},{"id":"T664","span":{"begin":19,"end":30},"obj":"Body_part"}],"attributes":[{"id":"A663","pred":"fma_id","subj":"T663","obj":"http://purl.org/sig/ont/fma/fma62864"},{"id":"A664","pred":"fma_id","subj":"T664","obj":"http://purl.org/sig/ont/fma/fma63261"}],"text":"tory monocytes and macrophages.\n(D) Several potential sources of SARS-CoV-2 neutralizing antibodies are currently under investigation, including monoclonal antibodies, polyclonal anti"}
LitCovid-PD-MONDO
{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T448","span":{"begin":65,"end":73},"obj":"Disease"}],"attributes":[{"id":"A448","pred":"mondo_id","subj":"T448","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"tory monocytes and macrophages.\n(D) Several potential sources of SARS-CoV-2 neutralizing antibodies are currently under investigation, including monoclonal antibodies, polyclonal anti"}
LitCovid-PD-CLO
{"project":"LitCovid-PD-CLO","denotations":[{"id":"T850","span":{"begin":5,"end":14},"obj":"http://purl.obolibrary.org/obo/CL_0000576"}],"text":"tory monocytes and macrophages.\n(D) Several potential sources of SARS-CoV-2 neutralizing antibodies are currently under investigation, including monoclonal antibodies, polyclonal anti"}
LitCovid-PubTator
{"project":"LitCovid-PubTator","denotations":[{"id":"2374","span":{"begin":65,"end":75},"obj":"Species"}],"attributes":[{"id":"A2374","pred":"tao:has_database_id","subj":"2374","obj":"Tax:2697049"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"tory monocytes and macrophages.\n(D) Several potential sources of SARS-CoV-2 neutralizing antibodies are currently under investigation, including monoclonal antibodies, polyclonal anti"}